Development of prognostic factors and survival in cutaneous melanoma over 25 years

Recent studies revealed that incidence rates of cutaneous melanoma (CM) were leveling off predominantly among younger people and patterns suggested birth‐cohort effects. The current study analyzed the development of prognostic factors and survival in incident CM over 25 years.

[1]  J. Hunter.  CUTANEOUS MALIGNANT MELANOMA , 1976, International journal of dermatology.

[2]  L. Dennis,et al.  Recent cohort trends in malignant melanoma by anatomic site in the United States , 1993, Cancer Causes & Control.

[3]  D. Miller,et al.  Update on the incidence and mortality from melanoma in the United States. , 1999, Journal of the American Academy of Dermatology.

[4]  P. Boyle,et al.  Mortality from cutaneous melanoma: evidence for contrasting trends between populations , 2000, British Journal of Cancer.

[5]  U. Ringborg.  Review: Cutaneous Malignant Melanoma , 1996 .

[6]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  C. Stegmaier,et al.  Cancer registration in Germany: current status, perspectives and trends in cancer incidence 1973-93. , 2000, Journal of epidemiology and biostatistics.

[8]  U. Ringborg,et al.  Trends in Incidence of Cutaneous Malignant Melanoma in a Swedish Population 1976-1994 , 2002, Acta oncologica.

[9]  J. Bulliard,et al.  Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. , 2000, International journal of epidemiology.

[10]  J. Hunter,et al.  Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94 , 1997, BMJ.

[11]  W. Shingleton.  Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide , 1985 .

[12]  L. Dennis,et al.  Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. , 1999, Archives of dermatology.

[13]  Hursthouse Mw.  Melanoma incidence and trends in the Nelson-Marlborough area of New Zealand. , 1992 .

[14]  B. Armstrong,et al.  Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996 , 2001, International journal of cancer.

[15]  L. Gaudette,et al.  Changing trends in melanoma incidence and mortality. , 1998, Health reports.

[16]  H. Kittler,et al.  A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999). , 2001, Wiener klinische Wochenschrift.

[17]  TR Hawkins.  Re-reading Silent Spring. , 1994, Environmental health perspectives.

[18]  N. Martin,et al.  Increasing incidence of cutaneous melanoma in Queensland, Australia. , 1992, Journal of the National Cancer Institute.

[19]  J. Holt.  CHANGING EPIDEMIOLOGY OF MALIGNANT MELANOMA IN QUEENSLAND , 1980, The Medical journal of Australia.

[20]  Gernot Rassner,et al.  Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients , 1995, Cancer.

[21]  O. Gefeller,et al.  Public awareness of malignant melanoma risk factors in Germany. , 1997, Journal of epidemiology and community health.

[22]  K. Magnus.  Habits of sun exposure and risk of malignant melanoma: An analysis of incidence rates in Norway 1955–1977 by cohort, sex, age, and primary tumor site , 1981, Cancer.

[23]  K. Jöckel,et al.  Skin melanoma in Saarland: incidence, survival and mortality 1970–1996 , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[24]  J. Birdsell,et al.  Cutaneous malignant melanoma in Alberta: 1967–1976 , 1983, Cancer.

[25]  A. Andersen,et al.  Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. , 1986, Acta pathologica, microbiologica, et immunologica Scandinavica. Supplement.

[26]  B K Armstrong,et al.  Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? , 1988, The Journal of dermatologic surgery and oncology.

[27]  F. Bray,et al.  Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia , 2003, International journal of cancer.

[28]  P. Altmeyer,et al.  A local education campaign on early diagnosis of malignant melanoma , 1993, European Journal of Epidemiology.

[29]  C. la Vecchia,et al.  Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age , 1999, International journal of cancer.

[30]  J. Bulliard,et al.  Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969–93 , 1999, Cancer Causes & Control.

[31]  N. Davis,et al.  CHANGING EPIDEMIOLOGY OF MALIGNANT MELANOMA IN QUEENSLAND , 1980, The Medical journal of Australia.

[32]  D L Morton,et al.  Multivariate analysis of the relationship between survival and the microstage of primary melanoma by clark level and breslow thickness , 1993, Cancer.

[33]  A. Jemal,et al.  Recent trends in cutaneous melanoma incidence among whites in the United States. , 2001, Journal of the National Cancer Institute.

[34]  K. Jöckel,et al.  Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. , 2003, Annals of epidemiology.

[35]  C. la Vecchia,et al.  Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland , 1998, International journal of cancer.

[36]  A. Streetly,et al.  Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. , 1995, International journal of epidemiology.

[37]  B. Kulle,et al.  Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10433 patients. Evolution of gender differences and malignancy. , 2002, European journal of cancer.

[38]  J. Doré,et al.  Time trends of cutaneous melanoma in Queensland, Australia and Central Europe , 2002, Cancer.

[39]  R. MacKie,et al.  Cutaneous malignant melanoma, Scotland, 1979-89 , 1992, The Lancet.

[40]  D. Silverman,et al.  Cancer incidence and mortality trends among whites in the United States, 1947-84. , 1987, Journal of the National Cancer Institute.